GT200500044A - Dispersiones moleculares de drospirenona - Google Patents

Dispersiones moleculares de drospirenona

Info

Publication number
GT200500044A
GT200500044A GT200500044A GT200500044A GT200500044A GT 200500044 A GT200500044 A GT 200500044A GT 200500044 A GT200500044 A GT 200500044A GT 200500044 A GT200500044 A GT 200500044A GT 200500044 A GT200500044 A GT 200500044A
Authority
GT
Guatemala
Prior art keywords
drospirenona
compositions
molecular dispersions
biodavailability
costable
Prior art date
Application number
GT200500044A
Other languages
English (en)
Spanish (es)
Inventor
Adrian Funke
Torsten Wagner
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200500044A publication Critical patent/GT200500044A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GT200500044A 2004-03-10 2005-03-10 Dispersiones moleculares de drospirenona GT200500044A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04075713 2004-03-10

Publications (1)

Publication Number Publication Date
GT200500044A true GT200500044A (es) 2005-10-31

Family

ID=34928104

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200500044A GT200500044A (es) 2004-03-10 2005-03-10 Dispersiones moleculares de drospirenona

Country Status (12)

Country Link
CN (1) CN1980636A (zh)
AR (1) AR048002A1 (zh)
DE (1) DE602005022952D1 (zh)
GT (1) GT200500044A (zh)
MY (1) MY143870A (zh)
PA (1) PA8625901A1 (zh)
PE (1) PE20060004A1 (zh)
RS (1) RS50975B (zh)
SV (1) SV2005002043A (zh)
TW (2) TW200609000A (zh)
UA (1) UA90263C2 (zh)
UY (1) UY28802A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106109420B (zh) * 2016-08-11 2018-07-06 吴启旸 依普利酮固体分散体及其制剂

Also Published As

Publication number Publication date
UY28802A1 (es) 2005-10-31
UA90263C2 (en) 2010-04-26
DE602005022952D1 (de) 2010-09-23
CN1980636A (zh) 2007-06-13
PE20060004A1 (es) 2006-02-16
AR048002A1 (es) 2006-03-15
SV2005002043A (es) 2005-11-04
RS50975B (sr) 2010-10-31
MY143870A (en) 2011-07-15
PA8625901A1 (es) 2006-07-03
TW200609000A (en) 2006-03-16
TW200840587A (en) 2008-10-16

Similar Documents

Publication Publication Date Title
BRPI0508612A (pt) composições compreendendo drospirenona dispersa molecularmente
MA37809B1 (fr) Administration de médicament biodégradable pour compositions hydrophobes
CL2007001724A1 (es) Uso de un estrogeno para el tratamiento de enfermedades, condiciones o sintomas asociados con niveles deficientes de estrogenos en una mujer; composicion farmaceutica que comprende unidades de dosificacion diarias de hemidrato de estradiol > 0,75 y 1
CO6690737A2 (es) Composicion química estabilizada
CO6280466A2 (es) Forma de dosificacion farmaceutica de liberacion controlada
WO2009074351A3 (en) Solid forms of tenofovir disoproxil
AR060784A1 (es) Mezclas binarias de acido hialuronico y su uso terapeutico
HN2006009000A (es) Formas farmaceuticas con propiedades farmacocineticas mejoradas
UY37086A (es) Moléculas que tienen utilidad plaguicida y productos intermedios, composiciones y procesos, relacionados con las mismas
TR201004346T2 (tr) Depresyon ve anksiyetenin tedavisinde farmasötikal kompozisyonlar.
McGowan An overview of antiretroviral pre‐exposure prophylaxis of HIV infection
BRPI0513938A (pt) composição farmacêutica contendo drospirenona e etinilestradiol
WO2008107611A3 (fr) Formulation du dimethylsulfoxyde en melange avec un additif permettant d'abaisser le point de cristallisation de ce dernier, et applications de ce melange
AR064104A1 (es) Formas de dosificacion en microemulsion de valsartan, y metodos para elaborarlas
GT200500044A (es) Dispersiones moleculares de drospirenona
CL2012001085A1 (es) Un producto listo para el consumo gelatinizado a base de agua, jugo, y/o leche que comprende al menos dos masas de gel homogeneas independientes, en el que las masas de gel independientes adyacentes tienen resistencia de gel diferentes.
Huang et al. Steroidal Amides with Biological Activities
Kim et al. Evaluation of the genetic toxicity of synthetic chemical (XVIII)-in vitro mouse lymphoma assay and in vivo supravital micronucleus assay with butylated hydroxytoluene (BHT)
Tailaiti et al. Urination Treatment Drug Oleanolic Acid Affects the Therapy Index of Zidovudine (AZT)
CO6382128A2 (es) Tratamiento de atrofia vaginal en mujeres con riesgo de patologia cardiovascular
Cole Pre-degree pilot has its uses… and its limitations
梁璐茜 Should We Wear School Uniforms
Setswe Review, update and definition of indicators to monitor the social impacts and other aspects of HIV and AIDS in South Africa
TH93875B (th) สารผสมตามสูตรที่ออกฤทธิ์ช้า ซึ่งประกอบด้วยออกทรีโอไทด์และพอลิแลคไทด์-โค-ไกลโคไลด์ พอลิเมอร์สองตัวหรือมากกว่า
TH95064A (th) สูตรผสมในทางเภสัชกรรม